39 Concurrent use of a GLP-1RA and SGLT-2 inhibitor is safe and effective
A recommendation for early termination due to safety reasons will be considered by the independent DSMB if the Haybittle-Peto boundary (p=0.001, Z=3) at a given interim analysis is crossed
On December 22, 2008, FDA warned consumers not to purchase or consume 28 different products marketed for weight loss
The Science Behind Better Sleep Research Findings Multiple studies show promising results for GLP-1 therapy and sleep: A 2024 systematic review found that GLP-1 medications significantly reduced sleep apnea severity scores by an average of 6-12 events per hour compared to placebo
During statistical analysis, a two-way ANOVA test helped examine the differences in the amino acids, fatty acids, proximate composition, mineral bioaccessibility, antioxidant capacity, folates, and TPC content across all bread samples studied
Neuronal autophagy and neurodevelopmental disorders